Prostate‐specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study)-Reference-Cited by-同舟云学术

Prostate‐specific antigen density during dutasteride treatment for 1 year predicts the presence of prostate cancer in benign prostatic hyperplasia after the first negative biopsy (PREDICT study)

Published:2021-05-18 Issue:8 Volume:28 Page:849-854
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int. J. Urol.

Author:

Inoue Takaaki¹²,Yoshimura Koji³,Terada Naoki⁴,Tsukino Hiromasa⁴,Murota Takashi⁵,Kinoshita Hidefumi⁶,Kamoto Toshiyuki⁴,Ogawa Osamu⁷,Matsuda Tadashi⁶

Affiliation:

1. Division of Urology Department of Surgery Related Kobe University Graduate School of Medicine HyogoJapan

2. Department of Urology and Stone Center Hara Genitourinary Hospital HyogoJapan

3. Department of Urology Shizuoka General Hospital ShizuokaJapan

4. Department of Urology Faculty of Medicine Miyazaki University MiyazakiJapan

5. Department of Urology General Medical Center Kansai Medical University OsakaJapan

6. Department of Urology and Andrology Kansai Medical University OsakaJapan

7. Department of Urology Kyoto University Hospital Kyoto Japan

Publisher

Wiley

Subject

Urology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14590

Reference25 articles.

1. Possibility of re-screening intervals of more than one year in men with PSA levels of 4.0 ng/ml or less

2. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial

3. National Comprehensive Cancer Network (NCCN).Clinical Practice Guidelines in Oncology. Prostate Cancer Early Detection USA. Version 2.2010.

4. PREDICTORS OF FIRST REPEAT BIOPSY CANCER DETECTION WITH SUSPECTED LOCAL STAGE PROSTATE CANCER

5. MottetN CornfordP van denBerghRCNet al.European Association of Urology (EAU) Guideline 2020. Prostate Cancer 5.2.4; Guideline for imaging in prostate cancer detections.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and temporal trends of prostate diseases among inpatients with cardiovascular disease: a nationwide real-world database survey in Japan;Frontiers in Cardiovascular Medicine;2023-10-19

2. Evaluation of sexual function after dutasteride treatment in patients with once-negative prostate biopsy and benign prostate hyperplasia;Urologia Journal;2023-03-29

3. Risk Analysis of Prostate Cancer Development Following Five-alpha Reductase Inhibitor Treatment for Benign Prostate Hyperplasia;Anticancer Research;2022-12-30